Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance

被引:344
作者
Bubici, C. [1 ]
Papa, S. [1 ]
Dean, K. [1 ]
Franzoso, G. [1 ]
机构
[1] Univ Chicago, Ben May Inst Canc Res, Chicago, IL 60637 USA
关键词
NF-kappa B; ROS; JNK; TNF; apoptosis; necrosis;
D O I
10.1038/sj.onc.1209936
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Reactive oxygen species (ROS) are emerging as key effectors in signal transduction. This role of ROS is especially evident in the pathways leading to programmed cell death (PCD) elicited in response to certain stress stimuli and cytokines. In these pathways, cytotoxic ROS signaling appears to be mediated in part by activation of the c-Jun-N-terminal kinase (JNK) mitogen-activated protein kinase (MAPK) cascade. Another pathway that is under ROS-mediated control in some systems is that leading to activation of transcription factor nuclear factor-kappa B (NF-kappa B), which is a central regulator of immunity, inflammation and cell survival. Remarkably, new evidence has unveiled the existence of a reciprocal, negative control that NF-kappa B exerts on ROS and JNK activities. This NF-kappa B-imposed restraint on ROS and JNK signaling is crucial for antagonism of PCD elicited by the proinflammatory cytokine tumor necrosis factor (TNF)alpha and likely other triggers. Effectors of this antagonistic cross-talk between NF-kappa B and ROS/JNK pathways have recently been identified. Because of the key roles that the prosurvival function of NF-kappa B plays in organismal physiology and disease, gaining a further mechanistic understanding of this cross-talk and NF-kappa B-dependent survival may be key to developing new therapies for the treatment of widespread human illnesses, such as cancer and chronic inflammatory conditions.
引用
收藏
页码:6731 / 6748
页数:18
相关论文
共 155 条
  • [61] Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha
    Imbert, V
    Rupec, RA
    Livolsi, A
    Pahl, HL
    Traenckner, EBM
    MuellerDieckmann, C
    Farahifar, D
    Rossi, B
    Auberger, P
    Baeuerle, PA
    Peyron, JF
    [J]. CELL, 1996, 86 (05) : 787 - 798
  • [62] Caspase-independent cell death in T lymphocytes
    Jäättelä, M
    Tschopp, J
    [J]. NATURE IMMUNOLOGY, 2003, 4 (05) : 416 - 423
  • [63] Recent advances towards understanding redox mechanisms in the activation of nuclear factor κB
    Janssen-Heininger, YMW
    Poynter, ME
    Baeuerle, PA
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2000, 28 (09) : 1317 - 1327
  • [64] Hydrogen peroxide has opposing effects on IKK activity and IκBα breakdown in airway epithelial cells
    Jaspers, I
    Zhang, WL
    Fraser, A
    Samet, JM
    Reed, W
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2001, 24 (06) : 769 - 777
  • [65] Regulatory role for a novel human thioredoxin peroxidase in NF-κB activation
    Jin, DY
    Chae, HZ
    Rhee, SG
    Jeang, KT
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (49) : 30952 - 30961
  • [66] Redox regulation of NF-κB activation:: Distinct redox regulation between the cytoplasm and the nucleus
    Kabe, Y
    Ando, K
    Hirao, S
    Yoshida, M
    Handa, H
    [J]. ANTIOXIDANTS & REDOX SIGNALING, 2005, 7 (3-4) : 395 - 403
  • [67] Reactive oxygen species promote TNFα-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases
    Kamata, H
    Honda, S
    Maeda, S
    Chang, LF
    Hirata, H
    Karin, M
    [J]. CELL, 2005, 120 (05) : 649 - 661
  • [68] Inhibition of NF-κB activation by arsenite through reaction with a critical cysteine in the activation loop of IκB kinase
    Kapahi, P
    Takahashi, T
    Natoli, G
    Adams, SR
    Chen, Y
    Tsien, RY
    Karin, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (46) : 36062 - 36066
  • [69] From JNK to pay dirt: Jun kinases, their biochemistry, physiology and clinical importance
    Karin, M
    Gallagher, E
    [J]. IUBMB LIFE, 2005, 57 (4-5) : 283 - 295
  • [70] The IKKNF-κB system:: A treasure trove for drug development
    Karin, M
    Yamamoto, Y
    Wang, QM
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (01) : 17 - 26